ReviewTargeted oncology2023
Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC.
Tina Nie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewTargeted oncology2023
Tina Nie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.